Home > Healthcare > Medical Devices > Diagnostic Devices > Hepatitis Diagnostic Tests Market
Hepatitis Diagnostic Tests Market size was valued at around USD 3.4 billion in 2022 and is projected to witness over 5.8% CAGR from 2023 to 2032. Increasing prevalence of hepatitis is expected to augment the market growth.
Rising awareness regarding availability of several diagnostic tests for hepatitis screening has surged the market progress. Technological advancements pertaining to these diagnostic tests have fuelled the screening of blood sample, thereby resulting in better diagnosis and treatment. Availability of advanced detection techniques such as molecular diagnostics, nucleic acid assays, rapid diagnostic tests (RDTs) etc. is spurring the overall market revenue.
Hepatitis diagnostic tests are medical tests intended to detect the presence of hepatitis viruses and evaluate the extent of inflammation or damage of the liver caused by the virus. These tests detect antibodies or antigens associated with different types of hepatitis and measure various enzymes and proteins produced by the liver.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Hepatitis Diagnostic Tests Market Size in 2022: | USD 3.4 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.8% |
2032 Value Projection: | USD 5.9 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 185 |
Tables, Charts & Figures: | 520 |
Segments covered: | Product, Technology, Test Type, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Limited access to reliable and low-cost hepatitis diagnostic tests is a major public health concern. Moreover, this limited access is a major constraint particularly in resource-limited healthcare facilities. Hepatitis is a major cause of liver disease and can have serious long-term health consequences if left untreated. However, the cost of diagnostic tests, particularly for hepatitis B and C, can be excessively high and testing may not be available for patients in developing countries. Growing concern pertaining to the rising costs of these test is further compounded by the increasing demand for hepatitis screening in blood, thereby requiring these kits and devices for diagnosis.